Kerala Ayurveda logo

Kerala Ayurveda

KERALAAYURVEDALTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹229 Cr
Volatility
Moderate
P/E Ratio
-8.7
EBITDA
₹-17.75 Cr
Return on Equity
-108.29%
Debt to Equity
7.82
Book Value
₹8.79
EPS
₹0
52W High
₹503.9
52W Low
₹145

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Debtor days have improved from 51.1 to 38.4 days.

Weaknesses

5
  • Stock is trading at 20.4 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding is low: 35.6%
  • Company has a low return on equity of -85.2% over last 3 years.
  • Promoter holding has decreased over last 3 years: -25.9%

Growth Rate

Revenue Growth
7.32% lower than 3Y
Net Income Growth
16.57%
Cash Flow Change
603% higher than 3Y
ROE
—
ROCE
-246% higher than 3Y
EBITDA Margin (Avg.)
370% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
23.78
25.03
26.32
32.03
27.47
30.41
31.13
31.32
28.61
34.84
32.96
34.74
33.19
Expenses
22.25
24.49
25.31
26.58
26.67
24.88
32.32
41.46
32.8
39.79
34.47
41.84
37.02
Operating Profit
1.53
0.54
1.01
5.45
0.8
5.53
-1.19
-10.14
-4.19
-4.95
-1.51
-7.1
-3.83
OPM %
6.43%
2.16%
3.84%
17.02%
2.91%
18.18%
-3.82%
-32.38%
-14.65%
-14.21%
-4.58%
-20.44%
-11.54%
Other Income
0.16
0.77
0.23
-0.86
0.22
0.64
0.23
0.73
9.47
1.7
1.13
1.91
0.26
Interest
1.51
0.65
0.61
3.26
0.46
0.72
0.43
2.48
0.82
2.58
2.84
1.1
2.79
Depreciation
0.33
0.32
0.34
1.15
0.36
1.98
0.72
1.92
1.65
0.99
1.15
1.69
1.87
PBT
-0.15
0.34
0.29
0.18
0.2
3.47
-2.11
-13.81
2.81
-6.82
-4.37
-7.98
-8.23
Tax %
106.67%
100%
368.97%
-194.44%
-125%
-4.9%
27.96%
11.3%
27.76%
-6.74%
5.26%
-7.39%
-1.82%
Net Profit
-0.3
0
-0.79
0.53
0.46
3.65
-2.7
-15.38
2.03
-6.36
-4.6
-7.39
-8.08
EPS in Rs
-0.34
-0.12
-0.9
0.22
0.27
2.84
-2.4
-12.92
1.65
-5.26
-3.69
-5.97
-6.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
39
46
50
59
59
77
62
80
93
108
126
131
136
Expenses
33
38
43
51
54
69
61
71
91
100
131
149
153
Operating Profit
6
8
7
8
5
7
1
10
3
9
-5
-18
-17
OPM %
15%
16%
14%
14%
9%
10%
1.4%
12%
2.8%
8%
-4%
-14%
-13%
Other Income
0
0
0
0
1
0
0
1
3
0
2
14
5
Interest
2
2
1
2
3
2
6
7
5
6
4
7
9
Depreciation
1
2
2
2
1
1
1
1
1
2
5
5
6
PBT
3
4
4
4
3
5
-7
3
-1
1
-12
-16
-27
Tax %
21%
33%
22%
31%
19%
11%
-28%
15%
-23%
185%
14%
0%
—
Net Profit
3
3
3
3
3
4
-5
2
0
-1
-14
-16
-26
EPS in Rs
2.24
2.56
2.9
2.66
2.31
3.69
-4.59
2.24
-0.85
-0.47
-11.6
-12.74
-21.06
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
11
11
11
11
11
11
11
11
11
12
12
13
Reserves
-19
-17
-4
-3
-7
-3
-7
-4
-5
7
-3
-2
Borrowings
70
69
56
75
62
64
77
70
72
76
71
86
Other Liabilities
11
11
17
20
27
31
34
34
37
38
49
41
Total Liabilities
73
73
81
103
92
103
114
110
115
133
129
138
Fixed Assets
33
34
34
32
33
33
33
44
46
41
47
50
CWIP
0
0
6
11
12
14
14
4
7
7
9
8
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
40
39
41
59
47
56
68
62
61
85
73
81
Total Assets
73
73
81
103
92
103
114
110
115
133
129
138
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
6
4
-10
12
5
7
0
10
-1
5
-24
Investing
0
-3
-3
-3
-3
-4
-1
-2
-7
0
-15
-5
Financing
2
-2
0
17
-12
1
6
-13
-2
20
-9
32
Net Cash Flow
2
0
1
4
-2
2
12
-16
0
18
-19
3
Free Cash Flow
0
2
3
-16
10
2
6
-3
4
-2
-8
-30
CFO/OP
8
73
62
-120
251
71
885
-5
390
1
-138
136
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
35
33
35
34
43
51
61
61
51
59
56
38
Inventory Days
287
227
319
338
311
313
268
254
227
205
208
200
Days Payable
150
100
112
125
117
162
149
168
137
114
93
129
Cash Conversion Cycle
172
160
242
247
236
202
179
147
141
149
171
109
Working Capital Days
-131
-103
-213
-63
-24
-19
-99
-118
-81
-172
-147
-162
ROCE %
8%
9%
9%
9%
6%
9%
0%
11%
2%
8%
-9%
-10%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Kerala Ayurveda insights

63 extracted metrics + investor summaries across FY06–FY26.

Log in — free

Shareholding Pattern

DIIs0.04%Public42.02%FIIs0.17%Others22.17%Promot.35.61%As ofJun 2026
20.35% of promoter holding pledged as of 10 Sep 2026

Documents

Frequently Asked Questions about Kerala Ayurveda

What does Kerala Ayurveda Ltd do?
Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]
Where is Kerala Ayurveda Ltd (530163) listed?
Kerala Ayurveda Ltd trades as KERALAAYURVEDALTD on the NSE and under code 530163 on the BSE.
Which sector does Kerala Ayurveda Ltd belong to?
Kerala Ayurveda Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has a market capitalisation of ₹228.66 Cr, which places it in the Small Cap band.
What is the PE ratio of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd trades at a PE ratio of -8.70, on earnings per share of ₹0, against a book value of ₹8.79 per share.
What is the 52-week high and low of Kerala Ayurveda Ltd?
Over the last 52 weeks Kerala Ayurveda Ltd has traded between ₹145 and ₹503.9.
What is the Return on Equity (ROE) of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd reported a return on equity of -108.29%. Its debt-to-equity ratio is 7.82.

Company Information

Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]

Website keralaayurveda.biz
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530163.md for Kerala Ayurveda Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List